SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Norris Medicines - Quaterly Results

14 Aug 2025 Evaluate
The total revenue for the June 2025 quarter zoomed 100.97% to Rs. 14.57 millions as compared to Rs. 7.25 millions during the year-ago period.The Net Loss for the quarter ended June 2025 is Rs. -3.12 millions as compared to Net Loss of Rs. -3.66 millions of corresponding quarter ended June 2024 Operating profit Margin for the quarter ended June 2025 improved to -0.77% as compared to -1.50% of corresponding quarter ended June 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 14.57 7.25 100.97 14.57 7.25 100.97 58.20 56.36 3.26
Other Income 0.24 0.12 100.00 0.24 0.12 100.00 0.61 0.28 117.86
PBIDT -0.77 -1.50 -48.67 -0.77 -1.50 -48.67 -2.01 -1.57 28.03
Interest 1.12 0.84 33.33 1.12 0.84 33.33 4.40 3.70 18.92
PBDT -1.89 -2.34 -19.23 -1.89 -2.34 -19.23 -6.41 -5.27 21.63
Depreciation 1.23 1.32 -6.82 1.23 1.32 -6.82 5.37 5.72 -6.12
PBT -3.12 -3.66 -14.75 -3.12 -3.66 -14.75 -11.78 -10.99 7.19
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.59 0.89 -33.71
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.59 0.89 -33.71
PAT -3.12 -3.66 -14.75 -3.12 -3.66 -14.75 -12.37 -11.88 4.12
Equity 99.26 99.26 0.00 99.26 99.26 0.00 99.26 99.26 0.00
PBIDTM(%) -5.28 -20.69 -74.46 -5.28 -20.69 -74.46 -3.45 -2.79 23.98

Norris Medicines Share Price

14.22 -0.02 (-0.14%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×